VYNE Therapeutics
VYNE
VYNE
41 hedge funds and large institutions have $1.84M invested in VYNE Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less capital invested
Capital invested by funds: $3.25M → $1.84M (-$1.41M)
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$19K | |
| 2 | +$15.5K | |
| 3 | +$11K | |
| 4 |
Millennium Management
New York
|
+$7.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6K |
Top Sellers
| 1 | -$50K | |
| 2 | -$33.7K | |
| 3 | -$16K | |
| 4 |
RC
RegentAtlantic Capital
Morristown,
New Jersey
|
-$10K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7K |